Hardik Shah
2026.07.16 12:35

๐Ÿ“ข ๐‰๐”๐’๐“ ๐ˆ๐: $Tempus AI(TEM.US) Tempus Study Shows AI Improves Prostate Cancer Diagnosis and Lab Efficiency

๐Ÿ‘‰ ๐Š๐ž๐ฒ ๐‡๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ:

โžค ๐€๐ซ๐ญ๐ข๐œ๐ฎ๐ฅ๐š๐ญ๐ž ๐๐ซ๐จ study results published in ๐๐š๐ญ๐ฎ๐ซ๐ž ๐ƒ๐ข๐ ๐ข๐ญ๐š๐ฅ ๐Œ๐ž๐๐ข๐œ๐ข๐ง๐ž.

โžค ๐๐š๐ข๐ ๐ž ๐๐ซ๐จ๐ฌ๐ญ๐š๐ญ๐ž assisted pathologists in updating diagnoses for ๐’% of patients.

โžค ๐ˆ.๐Ÿ‘% of AI-assisted changes could potentially alter clinical management.

โžค Study evaluated biopsies from more than ๐ˆ,๐ŸŽ๐ŸŽ๐ŸŽ patients across three UK NHS trusts.

โžค AI improved ๐๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ consistency by detecting subtle cancer lesions.

โžค Laboratories reported results delivered nearly ๐จ๐ง๐ž ๐๐š๐ฒ sooner.

โžค AI reduced requests for additional ๐ข๐ฆ๐ฆ๐ฎ๐ง๐จ๐ก๐ข๐ฌ๐ญ๐จ๐œ๐ก๐ž๐ฆ๐ข๐ฌ๐ญ๐ซ๐ฒ (๐ˆ๐‡๐‚) staining.

โžค Findings indicate improved ๐ฅ๐š๐›๐จ๐ซ๐š๐ญ๐จ๐ซ๐ฒ efficiency and resource utilization.

โžค Paige Prostate Suite is part of the ๐“๐ž๐ฆ๐ฉ๐ฎ๐ฌ intelligent diagnostics ecosystem.

๐Ÿ‘‰ ๐„๐ฑ๐ฉ๐ž๐ซ๐ญ ๐’๐ญ๐š๐ญ๐ž๐ฆ๐ž๐ง๐ญ:

๐‘๐š๐ณ๐ข๐ค ๐˜๐จ๐ฎ๐ฌ๐Ÿ๐ข, Senior Vice President and General Manager of AI Products at Tempus:

"The rigorous, real-world results in the Articulate Pro study are a massive step forward for the global adoption of digital pathology. Integration of the Paige Prostate Suite directly into routine workflows shows that AI doesn't just work in a sandbox; it can actively alleviate the immense pressure on overstretched laboratories, cut down reporting times and give pathologists an extra layer of confidence when making critical diagnostic decisions."

The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.